Literature DB >> 18084094

Crystallization and preliminary crystallographic analysis of the Tob-hCaf1 complex.

Kinya Nishida1, Masataka Horiuchi, Nobuo N Noda, Kiyohiro Takahasi, Norimasa Iwasaki, Akio Minami, Fuyuhiko Inagaki.   

Abstract

The Tob/BTG family is a group of antiproliferative proteins that contain two highly homologous regions named Box A and Box B. These proteins all associate with CCR4-associated factor 1 (Caf1), which belongs to the ribonuclease D family of deadenylases. The antiproliferative region of human Tob (residues 1-138) and intact hCaf1 were co-expressed in Escherichia coli, purified and successfully cocrystallized. The crystal belongs to the tetragonal space group I422, with unit-cell parameters a = b = 150.9, c = 113.9 A, and is estimated to contain one heterodimer per asymmetric unit. The crystal diffracted to around 2.6 A resolution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18084094      PMCID: PMC2344109          DOI: 10.1107/S1744309107057466

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  20 in total

Review 1.  Messenger RNA turnover in eukaryotes: pathways and enzymes.

Authors:  Sylke Meyer; Claudia Temme; Elmar Wahle
Journal:  Crit Rev Biochem Mol Biol       Date:  2004 Jul-Aug       Impact factor: 8.250

2.  Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters.

Authors:  B S Fletcher; R W Lim; B C Varnum; D A Kujubu; R A Koski; H R Herschman
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

Review 4.  The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?

Authors:  F Tirone
Journal:  J Cell Physiol       Date:  2001-05       Impact factor: 6.384

5.  Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle.

Authors:  F Guéhenneux; L Duret; M B Callanan; R Bouhas; S Hayette; C Berthet; C Samarut; R Rimokh; A M Birot; Q Wang; J P Magaud; J P Rouault
Journal:  Leukemia       Date:  1997-03       Impact factor: 11.528

6.  Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases.

Authors:  N Ikematsu; Y Yoshida; J Kawamura-Tsuzuku; M Ohsugi; M Onda; M Hirai; J Fujimoto; T Yamamoto
Journal:  Oncogene       Date:  1999-12-09       Impact factor: 9.867

7.  Human carbon catabolite repressor protein (CCR4)-associative factor 1: cloning, expression and characterization of its interaction with the B-cell translocation protein BTG1.

Authors:  J A Bogdan; C Adams-Burton; D L Pedicord; D A Sukovich; P A Benfield; M H Corjay; J K Stoltenborg; I B Dicker
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

8.  Human TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation.

Authors:  Nader Ezzeddine; Tsung-Cheng Chang; Wenmiao Zhu; Akio Yamashita; Chyi-Ying A Chen; Zhenping Zhong; Yukiko Yamashita; Dinghai Zheng; Ann-Bin Shyu
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

9.  ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system.

Authors:  Y Yoshida; S Matsuda; N Ikematsu; J Kawamura-Tsuzuku; J Inazawa; H Umemori; T Yamamoto
Journal:  Oncogene       Date:  1998-05       Impact factor: 9.867

10.  BTG1, a member of a new family of antiproliferative genes.

Authors:  J P Rouault; R Rimokh; C Tessa; G Paranhos; M Ffrench; L Duret; M Garoccio; D Germain; J Samarut; J P Magaud
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more
  3 in total

1.  Tob1 is a constitutively expressed repressor of liver regeneration.

Authors:  Karen J Ho; Nhue L Do; Hasan H Otu; Martin J Dib; Xianghui Ren; Keiichi Enjyoji; Simon C Robson; Ernest F Terwilliger; Seth J Karp
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

2.  Alternative splicing of CNOT7 diversifies CCR4-NOT functions.

Authors:  Clément Chapat; Kamel Chettab; Pierre Simonet; Peng Wang; Pierre De La Grange; Muriel Le Romancer; Laura Corbo
Journal:  Nucleic Acids Res       Date:  2017-08-21       Impact factor: 16.971

3.  Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity.

Authors:  Xiuna Yang; Masahiro Morita; Hui Wang; Toru Suzuki; Wen Yang; Yunhai Luo; Cong Zhao; Yue Yu; Mark Bartlam; Tadashi Yamamoto; Zihe Rao
Journal:  Nucleic Acids Res       Date:  2008-10-30       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.